Transcranial Magnetic Stimulator Market Report 2026

Transcranial Magnetic Stimulator Market Overview

• Transcranial Magnetic Stimulator market size has reached to $1.39 billion in 2025 • Expected to grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Prevalence Of Neurological Diseases Drives Expansion Of Transcranial Magnetic Stimulator Market • Market Trend: Advanced Neuronavigation Systems Elevate Precision And Efficiency In TMS Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transcranial Magnetic Stimulator Market?

Transcranial magnetic stimulators (TMS) are non-invasive medical devices that employ magnetic waves to activate neurons in the nervous system in order to alleviate symptoms of depression. Transcranial magnetic stimulator (TMS) devices are used to activate neurons in the nervous system in order to alleviate symptoms of depression and other mental health and brain-related diseases. The main types of transcranial magnetic stimulators are deep transcranial magnetic stimulators (dTMS), repetitive TMS (rTMS), and others. Deep Transcranial Magnetic Stimulator (dTMS) refers to a type of transcranial magnetic stimulation (TMS) therapy that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. It is available for children and adults and is used in various applications such as Parkinson's disease, depression, Alzheimer's disease, epilepsy, and others.

What Is The Transcranial Magnetic Stimulator Market Growth Forecast?

The transcranial magnetic stimulator market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing adoption of tms for broader neurological indications, rising demand for personalized mental health treatments, expansion of outpatient psychiatric care, growing integration of digital treatment monitoring, increasing investments in neuromodulation research. Major trends in the forecast period include increasing adoption of non-invasive brain stimulation therapies, rising use of rtms in depression treatment, growing expansion of dtms clinical applications, enhanced focus on personalized neurostimulation protocols, expansion of outpatient mental health treatments.

What Is The Driver Of The Transcranial Magnetic Stimulator Market?

The increasing prevalence of neurological diseases is expected to drive the growth of the transcranial magnetic stimulator market. Transcranial magnetic stimulation (TMS) has shown promising results in treating various neurological and psychiatric illnesses. It is a new technique used to treat various neurological conditions such as stroke, spasticity, migraine, dementia, and movement disorders. For instance, in December 2022, a study by Parkinson's Foundation, a US-based non-profit organization, revealed that the number of people living with Parkinson's disease (PD) is estimated to increase to 1.2 million by 2030, up from 930,000 in 2020. Therefore, the increasing prevalence of neurological diseases is expected to propel the growth of the transcranial magnetic stimulator industry.

Key Players In The Global Transcranial Magnetic Stimulator Market

Major companies operating in the transcranial magnetic stimulator market are BrainsWay Ltd., Nexstim Plc., The Magstim Company Limited, Neuronetics Inc., MagVenture Inc., MAG & More GmbH, neurocare group AG, Neurosoft, Neuroelectrics, NeuroConn GmbH, Neurofield Inc., Axilum Robotics, Yiruide Neurotech, Brainbox Ltd., Remed Inc., Soterix Medical Inc., Sinovation Medical Technology Co. Ltd., Shenzhen Yingchi Technology Co. Ltd., Wuhan Greentek Bioengineering Co. Ltd., Vishee Medical Technology Co. Ltd.

Global Transcranial Magnetic Stimulator Market Trends and Insights

Major companies operating in the transcranial magnetic stimulator market are focusing on developing innovative advancements such as neuronavigational-guided TMS systems to improve coil placement accuracy, enhance treatment consistency, and streamline clinical workflows. A neuronavigational-guided TMS system refers to an image-based guidance platform that integrates patient-specific neuroimaging with real-time coil tracking to ensure precise and reproducible stimulation targeting during transcranial magnetic stimulation procedures. For instance, in March 2023, MagVenture Inc., a US-based medical equipment manufacturer, introduced the MagVenture TMS Atlas Neuro Navigation System. This system optimizes transcranial magnetic stimulator coil positioning with a time-saving, high-precision workflow that is reliable and easy to use. It provides high precision and accuracy for clinical use. Atlas provides the operator with a greater range of movement during TMS treatments by eliminating line-of-sight concerns. It uses advanced technology to provide patients with a visual depiction of their MRI scan as well as real-time tracking of the treatment coil to their head position, allowing them to be more involved in the procedure.

What Are Latest Mergers And Acquisitions In The Transcranial Magnetic Stimulator Market?

In December 2024, Neuronetics, Inc., a US-based provider of transcranial magnetic stimulation systems and neurotechnology solutions for mental health treatment, acquired Greenbrook TMS Inc. for an undisclosed amount. With this acquisition, Neuronetics aims to expand its treatment network, strengthen its commercial footprint, and accelerate access to transcranial magnetic stimulation therapies by integrating a large clinical service infrastructure with its technology platform. Greenbrook TMS Inc. is a Canada-based provider of outpatient transcranial magnetic stimulation services through a nationwide network of mental health treatment centers.

What Defines the Transcranial Magnetic Stimulator Market?

The transcranial magnetic stimulator market consists of sales of single-pulse and paired-pulse transcranial magnetic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transcranial Magnetic Stimulator Market Report 2026?

The transcranial magnetic stimulator market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transcranial magnetic stimulator industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.